CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleMarket cap is $1.26B, above the global median of $1.15B
- FinancialsAltman Z-Score 5.17: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
6.01%Above 5Y avg (3.97%)
Annual Rate
CNY 0.50Paid annual
Payout Ratio
46.9%Sustainable
Payback Period
16.6 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.49BCNY1.26B · vs all stocks (USD)
Trailing P/E
13.00xRevenue (TTM)
3.31BCNY491.03M · vs all stocks (USD)
Profit Margin
19.94%Beta
0.3550xvs all stocks
52-Week Change
-8.07%vs all stocks
Market Capitalization
8.49BCNY1.26B · vs all stocks (USD)
Enterprise Value
5.12BCNY758.70M · vs all stocks (USD)
Trailing P/E
13.00xForward P/E
11.72xPrice to Sales (TTM)
2.56xPrice to Book (MRQ)
2.74xEnterprise to Revenue
1.54xEnterprise to EBITDA
5.70xGross Margin
49.32%Profit Margin
19.94%Operating Margin
28.20%Return on Assets (TTM)
10.54%Return on Equity (TTM)
17.98%Revenue (TTM)
3.31BCNY491.03M · vs all stocks (USD)
Revenue per Share (TTM)
3.19CNYUpdated Aug 18, 2026Quarterly Revenue Growth
13.70%Gross Profit (TTM)
1.50BCNY222.45M · vs all stocks (USD)
EBITDA (TTM)
1.02BCNY151.09M · vs all stocks (USD)
Net Income (TTM)
660.09MCNY97.89M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
15.30%Operating Cash Flow (TTM)
1.06BCNY156.83M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
692.14MCNY102.64M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.5000CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
6.01%vs all stocks
5-Year Average Dividend Yield
3.97%vs all stocks
Payout Ratio
46.88%Revenue
3.17BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.75BCNYFY2025 · Dec 31, 2025Gross Profit
1.42BCNYFY2025 · Dec 31, 2025Operating Income
804.71MCNY119.34M · vs all stocks (USD)
Pre-tax Income
832.09MCNYFY2025 · Dec 31, 2025Income Tax Expense
204.99MCNYFY2025 · Dec 31, 2025Net Income
627.10MCNYFY2025 · Dec 31, 2025EBIT
842.07MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
891.93MCNYFY2025 · Dec 31, 2025Research & Development
9.16MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
370.78MCNYFY2025 · Dec 31, 2025Other Operating Expenses
30.80MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
41.71MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.97MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.6000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.6000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.05BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.05BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
627.10MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
703.05MCNYFY2025 · Dec 31, 2025Free Cash Flow
520.50MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.03BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
627.10MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.02MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
63.79MCNYFY2025 · Dec 31, 2025Capital Expenditures
-182.55MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-182.55MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
504.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-73.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-324.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-293.42MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-187.62MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.02BSharesUpdated Aug 18, 2026Float Shares
528.53MSharesUpdated Aug 18, 2026% Held by Insiders
48.02%vs all stocks
% Held by Institutions
7.01%vs all stocks
Total Cash (MRQ)
3.89BCNY577.48M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.92CNYUpdated Aug 18, 2026Total Debt (MRQ)
741.98MCNY110.04M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1999xCurrent Ratio (MRQ)
3.59xBook Value per Share (MRQ)
3.04CNYUpdated Aug 18, 2026Total Assets
5.31BCNY787.62M · vs all stocks (USD)
Total Current Assets
4.23BCNYFY2025 · Dec 31, 2025Total Liabilities
1.82BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.08BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
589.48MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.23BCNYFY2025 · Dec 31, 2025Cash
907.91MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.12BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.03BCNYFY2025 · Dec 31, 2025Accounts Receivable
14.17MCNYFY2025 · Dec 31, 2025Inventory
172.26MCNYFY2025 · Dec 31, 2025Accounts Payable
618.88MCNYFY2025 · Dec 31, 2025Short-term Debt
96.88MCNYFY2025 · Dec 31, 2025Other Current Liabilities
11.56MCNYFY2025 · Dec 31, 2025Long-term Debt
495.45MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.02BCNYFY2025 · Dec 31, 2025Retained Earnings
2.19BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.49BCNY517.64M · vs all stocks (USD)
Treasury Stock
44.52MCNYFY2025 · Dec 31, 202552-Week Low
7.14CNYUpdated Aug 18, 202652-Week High
9.47CNYUpdated Aug 18, 202652-Week Change
-8.07%vs all stocks
Beta
0.3550xvs all stocks
50-Day MA
8.17CNYUpdated Aug 18, 2026200-Day MA
8.41CNYUpdated Aug 18, 2026Avg 10-Day Volume
17.70MSharesUpdated Aug 18, 2026Avg 30-Day Volume
17.34MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
0.6400CNYUpdated Aug 18, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.17: safe zoneNotable
Altman Z-Score: 5.17
High earnings qualityNotable
Earnings Quality Score: 0.55
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Market cap is $1.26B, above the global median of $1.15BNotable
Market cap (USD): 1,258,533,211.205Global Median: 1,146,734,693.424
Levered free cash flow is $102.64M, above the global median of $16.24MNotable
Levered free cash flow (USD): 102,644,385.728Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Jinhui Liquor Co. Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Intercos S.p.A.
Tier 1ProductionBrand-Compounding ConsumerFlowSenseMaking
Sun Corporation
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Manorama Industries Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Lotte Corporation
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Guoquan Food Shanghai Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Herbalife Ltd.
Tier 1ProductionBrand-Compounding ConsumerAttentionInterface
Cloetta AB
Tier 1ProductionBrand-Compounding ConsumerAttentionRisk
Emdoor Information Co. Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowInterface
Shandong Bailong Chuangyuan Biotechnology Co. Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Nazara Technologies Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Nexxen International Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Biomarin Pharmaceutical Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities